CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a Position Paper from the Fleischner society
- 1 June 2015
- journal article
- practice guideline
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 3 (6), 483-496
- https://doi.org/10.1016/s2213-2600(15)00096-x
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- A predictive tool for an effective use of 18F-FDG PET in assessing activity of sarcoidosisBMC Pulmonary Medicine, 2012
- High-resolution CT of complications of idiopathic fibrotic lung diseaseThe British Journal of Radiology, 2011
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsThe Lancet, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Classification of Parenchymal Abnormality in Scleroderma Lung Using a Novel Approach to Denoise Images Collected via a Multicenter StudyAcademic Radiology, 2008
- Fleischner Society: Glossary of Terms for Thoracic ImagingRadiology, 2008
- Acute Exacerbations of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- High Resolution Multidetector CT-Aided Tissue Analysis and Quantification of Lung FibrosisAcademic Radiology, 2007
- Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006